Terbinorm (terbinafine) spray 10.08 mg/ml. 20 ml. vial

Description

Terbinorm (terbinafine) spray 10.08 mg/ml. 20 ml. vial

Composition

active substance: terbinafine;

1 ml of the drug contains terbinafine hydrochloride 10.08 mg;

excipients: propylene glycol, macrogol 300, ethanol 96%, purified water.

Dosage form

Skin spray, solution.

Main physical and chemical properties: clear or slightly opalescent solution, colorless or yellowish.

Pharmacotherapeutic group

Antifungal agents for topical use.
ATX code D01A E15.

Pharmacological properties

This drug is included in the group of drugs for the treatment of mycoses.
The main active component of terbinafine is synthetic allylamine, which is highly effective against various dermatophyte fungi. In particular, it is active against trichophytosis, tonsurans, verrucosum, microsporum, pityrosporum, candida, epidermophytosis, and other types of dermatophyte fungi.
When used in small doses, it has a fungicidal effect against dimorphic, mold and dermatophytes. Relative to Candida fungi, it produces both fungicidal and fungistatic effects.
Able to influence the early stage of biosynthesis of one of the most important components of fungal cell membranes – ergosterols. As a result, there is a shortage of egosterols and the accumulation of squalene inside the cell. As a result, the death of the fungal cell occurs.
It has a low degree of absorption into the body.

Indications

This drug Terbinorm spray is used to treat:

• fungal infections of the skin (trichophytosis of smooth skin and inguinal epidermophytosis), athlete’s feet (athlete’s foot);
• groin dermatophytosis (jockey’s itch);
• fungal skin infections caused by yeast (cutaneous candidiasis);
• multi-colored lichen.

Contraindications

The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or to one of the auxiliary components, hereditary fructose / maltose intolerance.
Contact with eyes should be avoided.
In pediatrics, it is used upon reaching the age of 12.

Application during pregnancy and lactation

This drug is contraindicated for pregnant women.
If it is necessary to take the drug during breastfeeding, lactation is suspended.

Method of administration and dosage

The drug Terbinorm spray is used externally, sprinkling it with a thin layer on thoroughly cleansed and dried skin (its affected area by the fungus), 1-2 times a day (depending on the type of disease and the strain of the fungus).
The drug is lightly rubbed both into the place of spread of the fungus, and capturing 1-2 cm around the affected skin.
If the skin is affected by a disease in the chest, groin, fingers, then after applying the cream, this place should be covered with gauze, gauze bandage (especially before going to bed).
Recommended courses of treatment:

• trichophytosis of smooth skin and inguinal epidermophytosis – 1 time per day, period – 1 week;
• Athlete’s foot – once a day, period – 1 week;
• candidiasis of the skin – 1 time per day, period – 2 weeks;
• versicolor versicolor – 1 time per day – 2 weeks.

If the effect is not noticeable within two weeks, the attending physician should be notified for re-evaluation of the diagnosis. If there is a need to continue the course of treatment, this can be done by the attending physician.
The faster you start taking the drug at the first signs of illness, the better the result.
Old age, liver or kidney disease are not reasons for adjusting the dosage, frequency or duration of treatment.

Overdose

Overdose (when applied topically) is unlikely due to low absorption of the drug through the skin.
If the cream is accidentally swallowed, you may experience:

• headache;
• abdominal pain;
• dizziness.

In this case, the symptoms should be treated – rinse the stomach, take enterosorbents.
When applied topically, itching and burning may occur, which quickly pass and do not require special treatment.

Side effects

The drug is usually well tolerated when used in the recommended doses.
Allergy may occur in case of individual intolerance. In particular, it can be observed:

• allergic reactions – itching, allergic urticaria, rash;
• burning of the skin at the site of application.